
Hemant Desai
Examiner (ID: 19091)
| Most Active Art Unit | 3721 |
| Art Unit(s) | 3731, 3721 |
| Total Applications | 1094 |
| Issued Applications | 787 |
| Pending Applications | 41 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14990671
[patent_doc_number] => 20190314293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => LOXAPINE FILM ORAL DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/455916
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/455916 | LOXAPINE FILM ORAL DOSAGE FORM | Jun 27, 2019 | Abandoned |
Array
(
[id] => 17520447
[patent_doc_number] => 20220106296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => CYANOTRIAZOLE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/253737
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253737 | CYANOTRIAZOLE COMPOUNDS AND USES THEREOF | Jun 17, 2019 | Abandoned |
Array
(
[id] => 15239447
[patent_doc_number] => 20190374509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => Methods of Using Metamizole for Treatment of Pyrexia in Equines
[patent_app_type] => utility
[patent_app_number] => 16/438130
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438130 | Methods of Using Metamizole for Treatment of Pyrexia in Equines | Jun 10, 2019 | Abandoned |
Array
(
[id] => 16992260
[patent_doc_number] => 20210230680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination
[patent_app_type] => utility
[patent_app_number] => 16/972873
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972873
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972873 | Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination | Jun 6, 2019 | Pending |
Array
(
[id] => 15264567
[patent_doc_number] => 20190381017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/433525
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433525 | Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof | Jun 5, 2019 | Abandoned |
Array
(
[id] => 17005277
[patent_doc_number] => 20210236438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/734869
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734869 | COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS | Jun 4, 2019 | Pending |
Array
(
[id] => 16990111
[patent_doc_number] => 20210228531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/734843
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734843 | TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS | Jun 4, 2019 | Pending |
Array
(
[id] => 16822645
[patent_doc_number] => 20210137938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NUPR1 INHIBITION FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/059297
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059297 | NUPR1 INHIBITION FOR TREATING CANCER | May 30, 2019 | Pending |
Array
(
[id] => 20414124
[patent_doc_number] => 12497394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/057199
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15368
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 505
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057199 | Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof | May 20, 2019 | Issued |
Array
(
[id] => 15206013
[patent_doc_number] => 20190365693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => INDUCTION OF ARTERIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/412749
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412749 | INDUCTION OF ARTERIOGENESIS | May 14, 2019 | Abandoned |
Array
(
[id] => 19491866
[patent_doc_number] => 12110564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
[patent_app_type] => utility
[patent_app_number] => 17/052882
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7797
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052882 | Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab | May 5, 2019 | Issued |
Array
(
[id] => 16655892
[patent_doc_number] => 20210052528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 17/051060
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051060 | THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16374948
[patent_doc_number] => 20200323790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL
[patent_app_type] => utility
[patent_app_number] => 16/382662
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382662 | METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL | Apr 11, 2019 | Abandoned |
Array
(
[id] => 18215181
[patent_doc_number] => 11590093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Kit, composition, and combination therapy for fragile X syndrome
[patent_app_type] => utility
[patent_app_number] => 16/383037
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 28
[patent_no_of_words] => 8161
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383037
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383037 | Kit, composition, and combination therapy for fragile X syndrome | Apr 11, 2019 | Issued |
Array
(
[id] => 15586247
[patent_doc_number] => 20200069658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => COMBINATION THERAPY FOR PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 16/381128
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381128 | COMBINATION THERAPY FOR PULMONARY HYPERTENSION | Apr 10, 2019 | Abandoned |
Array
(
[id] => 16374966
[patent_doc_number] => 20200323808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => WOUND TREATMENTS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/381975
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381975 | Wound treatments and compositions | Apr 10, 2019 | Issued |
Array
(
[id] => 16596510
[patent_doc_number] => 20210023041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => FORMULATIONS AND COMPOSITIONS OF DOCETAXEL
[patent_app_type] => utility
[patent_app_number] => 16/982772
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982772 | FORMULATIONS AND COMPOSITIONS OF DOCETAXEL | Apr 10, 2019 | Abandoned |
Array
(
[id] => 16533276
[patent_doc_number] => 10875859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Thymoquinone/harmaline and related reaction products
[patent_app_type] => utility
[patent_app_number] => 16/380279
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 8044
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380279
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380279 | Thymoquinone/harmaline and related reaction products | Apr 9, 2019 | Issued |
Array
(
[id] => 15586171
[patent_doc_number] => 20200069620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/379178
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379178 | Composition and method for muscle repair and regeneration | Apr 8, 2019 | Issued |
Array
(
[id] => 16726444
[patent_doc_number] => 20210093591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES
[patent_app_type] => utility
[patent_app_number] => 17/043966
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043966 | METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES | Mar 28, 2019 | Abandoned |